Stem Cell Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Stem Cell Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Stem Cell Transplantation
Cord stem cell transplant for primary immunodeficiencies comparable to other stem cell sources
August 14th, 2006
Umbilical cord blood stem cell transplantation for primary immunodeficiencies is comparable in efficacy to other stem cell sources. According to a recent report published in the journal Expert Opinion on Biological Therapy, "Primary immunodeficiencies (PIDs) are a rare but important cause of mortality and morbidity in childhood: the most severe, known as severe combined immunodeficiency (SCID), are fatal within the first year of life; other PIDs are less immediately life-threatening, but have a poor long-term outlook." "Hematopoietic stem cell transplantation (HSCT) is the best treatment for SCID and is increasingly offered for other PIDs. The...
Source: Stem Cell Week (2006-08-14)
|
